Parisi F, Fonti N, Millanta F, Freer G, Pistello M, Poli A
Infect Agent Cancer. 2023; 18(1):40.
PMID: 37386451
PMC: 10308683.
DOI: 10.1186/s13027-023-00518-7.
Lin L, Yao D, Wu L, Fan R, Liu Y, Zhou Z
Arch Virol. 2021; 167(1):189-194.
PMID: 34739587
PMC: 8570233.
DOI: 10.1007/s00705-021-05291-9.
Cloutier M, Nandi M, Ihsan A, Chamard H, Ilangumaran S, Ramanathan S
Cytokine. 2020; 136:155256.
PMID: 32866898
PMC: 7439999.
DOI: 10.1016/j.cyto.2020.155256.
Patel J, Heldens J, Bakonyi T, Rusvai M
Vaccine. 2012; 30(10):1767-81.
PMID: 22261411
PMC: 7130670.
DOI: 10.1016/j.vaccine.2012.01.014.
Drechsler Y, Alcaraz A, Bossong F, Collisson E, Diniz P
Vet Clin North Am Small Anim Pract. 2011; 41(6):1133-69.
PMID: 22041208
PMC: 7111326.
DOI: 10.1016/j.cvsm.2011.08.004.
Markers of feline leukaemia virus infection or exposure in cats from a region of low seroprevalence.
Beatty J, Tasker S, Jarrett O, Lam A, Gibson S, Noe-Nordberg A
J Feline Med Surg. 2011; 13(12):927-33.
PMID: 21880527
PMC: 10832971.
DOI: 10.1016/j.jfms.2011.07.011.
A review of feline infectious peritonitis virus infection: 1963-2008.
Pedersen N
J Feline Med Surg. 2009; 11(4):225-58.
PMID: 19254859
PMC: 7129802.
DOI: 10.1016/j.jfms.2008.09.008.
Suppressive effect on polyclonal B-cell activation of a synthetic peptide homologous to a transmembrane component of oncogenic retroviruses.
Mitani M, Cianciolo G, Snyderman R, Yasuda M, GOOD R, Day N
Proc Natl Acad Sci U S A. 1987; 84(1):237-40.
PMID: 3025858
PMC: 304178.
DOI: 10.1073/pnas.84.1.237.
Clinicopathologic responses in cats with feline leukemia virus-associated leukemia-lymphoma treated with staphylococcal protein A.
Engelman R, TYLER R, Trang L, Liu W, GOOD R, Day N
Am J Pathol. 1985; 118(3):367-78.
PMID: 2983560
PMC: 1887935.
Inhibition by human T-lymphotropic virus (HTLV-I) of T-lymphocyte mitogenesis: failure of exogenous T-cell growth factor to restore responsiveness to lectin.
Wainberg M, Spira B, Boushira M, Margolese R
Immunology. 1985; 54(1):1-7.
PMID: 2982729
PMC: 1454845.
Feline leukemia/sarcoma viruses and immunodeficiency.
Rojko J, Essex M, Trainin Z
Adv Vet Sci Comp Med. 1988; 32:57-96.
PMID: 2847504
PMC: 7271325.
DOI: 10.1016/b978-0-12-039232-2.50007-4.
Influence of inactivated feline retrovirus on feline alpha interferon and immunoglobulin production.
Yasuda M, GOOD R, Day N
Clin Exp Immunol. 1987; 69(2):240-5.
PMID: 2820639
PMC: 1542410.
Evaluation of immunity to feline infectious peritonitis in cats with cutaneous viral-induced delayed hypersensitivity.
Weiss R, Cox N
Vet Immunol Immunopathol. 1989; 21(3-4):293-309.
PMID: 2552650
PMC: 7133611.
DOI: 10.1016/0165-2427(89)90038-x.
Diseases associated with spontaneous feline leukemia virus (FeLV) infection in cats.
Reinacher M
Vet Immunol Immunopathol. 1989; 21(1):85-95.
PMID: 2549696
PMC: 7133624.
DOI: 10.1016/0165-2427(89)90132-3.
Characterization of a newly established feline lymphoma-derived cell line (BKD) lacking T and B cell surface markers.
Engelman R, Machida K, Longley R, Liu W, Trang L, GOOD R
In Vitro Cell Dev Biol. 1986; 22(5):273-9.
PMID: 2423498
DOI: 10.1007/BF02621230.
Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection.
Pedersen N, TORTEN M, Rideout B, Sparger E, Tonachini T, Luciw P
J Virol. 1990; 64(2):598-606.
PMID: 2153226
PMC: 249149.
DOI: 10.1128/JVI.64.2.598-606.1990.
Lymphocyte subset alterations and viral determinants of immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS.
Quackenbush S, Donahue P, Dean G, Myles M, Ackley C, Cooper M
J Virol. 1990; 64(11):5465-74.
PMID: 1976822
PMC: 248598.
DOI: 10.1128/JVI.64.11.5465-5474.1990.
Pathological features of lymphoid tissues in cats with natural feline immunodeficiency virus infection.
Brown P, Hopper C, Harbour D
J Comp Pathol. 1991; 104(4):345-55.
PMID: 1651959
PMC: 7130401.
DOI: 10.1016/s0021-9975(08)80145-4.
Immune mechanisms in the pathogenesis of viral diseases: a review.
TRAUTWEIN G
Vet Microbiol. 1992; 33(1-4):19-34.
PMID: 1481356
PMC: 7117483.
DOI: 10.1016/0378-1135(92)90032-o.